Carnegie acted as adviser to Biovitrum in the offer to all employees to purchase warrants issued by Biovitrum. Biovitrum is one of Europe’s largest biotechnology companies active in the research and development of small molecule drugs and recombinant protein drugs, as well as the manufacture of recombinant protein drugs.November, 2001.
Healthcare
Option program in Biovitrum (SE)
November 2001